Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
Genetron Holdings Ltd, a leading precision oncology platform in China also known as Genetron Health, announced on Tuesday ...
The reorganization supports Army acquisition reform and continuous adoption of commercial technologies for modern command-and ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...
The repayment satisfies the Company’s obligations under the Loan and Security Agreement originally entered into on October 29, 2021, with BroadOak Fund V, L.P. By retiring this debt early, Interpace ...
Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...
AWS has been building its own AI chips — and systems — for years now. It just released its third version, known as Trainium3, ...
POOLER, GA – December 01, 2025 – PRESSADVANTAGE – Concrete Placement Services has announced the expansion of its concrete pumping and concrete placement operations into the Savannah, Georgia market, ...
as an ordinary resolution, THAT the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2025 be ratified and that the directors of the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback